Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 2
2006 2
2008 2
2009 5
2010 3
2011 8
2012 10
2013 7
2014 14
2015 13
2016 16
2017 10
2018 8
2019 15
2020 13
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

119 results
Results by year
Filters applied: . Clear all
Page 1
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer.
Ai D, Yao J, Yang F, Huo L, Chen H, Lu W, Soto LMS, Jiang M, Raso MG, Wang S, Bell D, Liu J, Wang H, Tan D, Torres-Cabala C, Gan Q, Wu Y, Albarracin C, Hung MC, Meric-Bernstam F, Wistuba II, Prieto VG, Sahin AA, Ding Q. Ai D, et al. Among authors: huo l. Mod Pathol. 2021 Apr;34(4):710-719. doi: 10.1038/s41379-020-00692-8. Epub 2020 Oct 3. Mod Pathol. 2021. PMID: 33011748
Proliferative fasciitis mimicking sarcoma in the breast.
Yalniz C, Meis JM, Wang WL, Huo L, Candelaria RP, Adrada BE, Lane D, Santiago L, Huang ML. Yalniz C, et al. Among authors: huo l. Breast J. 2020 Oct;26(10):2072-2074. doi: 10.1111/tbj.14022. Epub 2020 Aug 27. Breast J. 2020. PMID: 32854140 No abstract available.
Diffuse alveolar hemorrhage with nivolumab monotherapy.
Shannon VR, Subudhi SK, Huo L, Faiz SA. Shannon VR, et al. Among authors: huo l. Respir Med Case Rep. 2020 Jun 11;30:101131. doi: 10.1016/j.rmcr.2020.101131. eCollection 2020. Respir Med Case Rep. 2020. PMID: 32577370 Free PMC article.
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer.
Yam C, Rauch GM, Rahman T, Karuturi M, Ravenberg E, White J, Clayborn A, McCarthy P, Abouharb S, Lim B, Litton JK, Ramirez DL, Saleem S, Stec J, Symmans WF, Huo L, Damodaran S, Sun R, Moulder SL. Yam C, et al. Among authors: huo l. Invest New Drugs. 2021 Apr;39(2):509-515. doi: 10.1007/s10637-020-00995-2. Epub 2020 Sep 28. Invest New Drugs. 2021. PMID: 32984932
119 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page